Shan Yang

Shan Yang is a Vice President at Joyance Partners, bringing expertise as a life sciences and health-tech investor with a deep scientific foundation.

Shan has a strong track record of commercializing disruptive genomics and diagnostic technologies, having led U.S. market entry and revenue growth for spatial transcriptomics at Complete Genomics and driven oncology marketing and medical affairs strategies at Illumina and Invitae.

Shan's experience spans business development, AI-driven analytics, and startup valuation.

Holding a Ph.D. in Biochemistry from Penn State and an MBA from Wharton, Shan provides sharp technical diligence and strategic insight for early-stage health-tech investments.

At Joyance Partners, Shan focuses on supporting companies leveraging science and technology to enhance well-being and daily life within the health and consumer sectors.

Bio is AI generated & may not be accurate.